Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer
Clinical trial NCT00132054 · COMPLETED
Trial details
- NCT number
- NCT00132054
- Sponsor
- Japan Multinational Trial Organization
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2006-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.